• Wed news: Novo and Viking heat up MASH space. New Pfizer R&D chief. Trump and the Biosecure Act. Sage Huntington’s prospect flunks trial. Dr. Oz to run CMS. See more on our front page


Idorsia contract

Quote
anonymous said:
Really? Out in the field making “sales” calls and don’t have a product to talk about but manager is coming to ride with me tomorrow? Not allowed to have lunch delivered for virtual lunches. Do they really think offices are going to schedule virtual appointments without a meal? This is a joke.
Click to expand...

I agree but the managers have a job to do and answer to the ASD. They have to make things look good. This is going to be very very tough.
 








rookies all of you pathetic UPS sampledroppers you should start looking for another job because there is no need for this product, third in class in a 90% plus generic market 2/3 of you will be dismissed by Thanksgiving

you will need C Czech to bring his stable of harlots to crank the wanks of all the high prescribing doctors who will get dinged by their insurance providers when prescribing non generic sleepers, doctors are not going to risk losing money for this product................enjoy your ride alongs
Yours truly,
Sales rep who went through same situation
 




anonymous said:
The unbranded campaign for a few months is going to be rough. Have other pharma companies done it this way before? I have never heard of it. They obviously wanted us onboard before Boston/drug launch. But they need to realize it's going to be hard to get in front of doctors with no product/samples/coupons. We have nothing. Then ride alongs on top of that with pressure to make it look good when we have nothing to get in back or talk to dr's about. It's almost unfair to ask them about Insomnia and their Insomnia patients when we have nothing to offer yet. It's going to actually going to turn some of them off.
Click to expand...
talked to office manager in huge target office and was told 3 physician practice writes all generic, too much hassle to get branded products approved and they will lose so called incentive monies paid by keeping drug costs down i.e generic utilization---- a metric measured closely by insurers
 




anonymous said:
talked to office manager in huge target office and was told 3 physician practice writes all generic, too much hassle to get branded products approved and they will lose so called incentive monies paid by keeping drug costs down i.e generic utilization---- a metric measured closely by insurers
Click to expand...

Don't companies do their research and know this? Why spend so much money and waste our time if this is the truth?
 








Should be a good opportunity, short term anyways. Remember, there are thousands of pharma reps displaced over last year or so. Sometimes you must fill in the gap with what is best for "now".
 




For those who are doubting, have you at least taken a look at their pipeline??? Resistant Hypertension, and a hart attack prevention are the next multi billion products they have in their pipeline. Furthermore Syneos is also expanding together with Idorsia in Europa.

Future is looking very bright!
 




anonymous said:
Keep hitting on the Hindu Kush ----------pipeline is filled with me three-four drugs, nothing novel about any of them besides C Czech will save the day with day passes to spa !
Click to expand...

Boy you are annoying and frustrated. Feel sorry for you…get a life!
 




Bankpas said:
For those who are doubting, have you at least taken a look at their pipeline??? Resistant Hypertension, and a hart attack prevention are the next multi billion products they have in their pipeline. Furthermore Syneos is also expanding together with Idorsia in Europa.

Future is looking very bright!
Click to expand...


Hart attack?
 




Bankpas said:
For those who are doubting, have you at least taken a look at their pipeline??? Resistant Hypertension, and a hart attack prevention are the next multi billion products they have in their pipeline. Furthermore Syneos is also expanding together with Idorsia in Europa.

Future is looking very bright!
Click to expand...

hart attack - solid hire
 




Bankpas said:
For those who are doubting, have you at least taken a look at their pipeline??? Resistant Hypertension, and a hart attack prevention are the next multi billion products they have in their pipeline. Furthermore Syneos is also expanding together with Idorsia in Europa.

Future is looking very bright!
Click to expand...

Dayvigo
 












True that, not alot of buzz/excitement so far in my field travels....all i am hearing so far is generics are way less cost and no paperwork for offices, hoping to get 2-3 years out of this , probably way less
 
























Top Bottom
Back
Quote